A tRNA-derived RNA fragment elevated in acute myeloid leukemia promotes cell growth and survival by suppressing AGGF1 and is ...

More than 120,000 people in the U.S. are living with acute lymphoblastic leukemia (ALL), and 6,000 new cases are diagnosed ...

NBA referee Scott Wall was diagnosed with acute myeloid leukemia earlier this year and is in treatment, the National ...

Schlabowske received his diagnosis at an urgent care clinic after a few weeks of feeling fatigued and nauseous, according to ...

A five-year National Cancer Institute grant will support efforts to identify biomarkers that predict response and relapse in ...

The investigational menin inhibitor is being evaluated in a registrational phase 2 trial for patients with relapsed or ...

Aptevo Therapeutics Inc. announced that ten patients with newly diagnosed acute myeloid leukemia (AML) have advanced to allogeneic stem cell transplant following treatment with mipletamig in ...

About TALZENNA® (talazoparib) TALZENNA is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair. Preclinical studies have demonstrated that TALZENNA blocks ...

Notably, ten of 47 (21%) evaluable frontline patients treated with mipletamig in combination with venetoclax and azacitidine (VEN+AZA) proceeded to allogeneic stem cell transplantation, a potentially ...

(Nasdaq:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today announced that ten patients with newly diagnosed acute myeloid leukemia (AML) ...

Researchers at the Center for Genomic Regulation (CRG) in Barcelona have developed a six-gene scoring system that could help predict survival outcomes in patients with acute myeloid leukemia (AML), an ...